Clinical Trial Update: An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis [Phase 2]

View source ↗

Summary

Pfizer's Phase 2 trial evaluating PD 0299685 for symptoms of interstitial cystitis/painful bladder syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis
• Painful Bladder Syndrome

Drugs mentioned

• PD 0299685

Snippet

Sponsor: Pfizer | Conditions: Interstitial Cystitis, Painful Bladder Syndrome | Phase 2 | Status: COMPLETED